Related Experiment Video
Updated: May 10, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Outcome of mitral valve plasty or replacement: atrial fibrillation an effect modifier
Background:
Advances in the understanding of mitral valve pathology have laid to mitral valve plasty (MPL) as the procedure of choice of all the mitral intervention as compared to mitral valve replacement (MVR).
Material And Methods:
A cohort of 355 patients with mitral valve disease operated between January 1993 to January 2007 with closing date first of mars 2011. There were 214 MPL and 141 MVR at the Hospital discharge. This retrospective cohort had the design of exposed (MPL) versus non-exposed (MVR) with outcome total mortality and reoperation during follow up. Also echocardiography follow-up was undertaken to estimate the true long-term failure rate of repair.
Results:
The mean follow up was 5.3 years SE (3.82) maximum follow up was 14.1 years. Considering the patient time model the association between repair/replacement and total mortality RR = 0.43 95% (0.28-074) p = 0.002 controlling for the confounding effect of 3-vessels disease. Those results were confirmed by propensity score analysis.
Conclusion:
In a cohort of patient with mitral valve disease undergoing MPL/MVR was examined. MPL was associated with better survival, and lower reoperation rate for patients without AF but same rate for patients with AF. We advocate more attention in controlling risk factors of AF in the clinical management of mitral disease. Long-term failure rate of MPL was low during follow up time. A replication of our results by a randomized clinical trial is mandatory.
Insights
Mitral valve plasty (MPL) offers better survival and lower reoperation rates compared to mitral valve replacement (MVR) for mitral valve disease. Careful management of atrial fibrillation risk factors is crucial for optimal outcomes with MPL.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery Outcomes
- Valvular Heart Disease
Background:
- Mitral valve plasty (MPL) is increasingly favored over mitral valve replacement (MVR) for mitral valve disease.
- Understanding long-term outcomes of MPL versus MVR is critical for clinical decision-making.
Purpose of the Study:
- To compare the total mortality and reoperation rates between MPL and MVR in patients with mitral valve disease.
- To evaluate the long-term failure rate of mitral valve plasty.
Main Methods:
- A retrospective cohort study of 355 patients undergoing MPL or MVR between 1993 and 2007.
- Outcomes assessed included total mortality and reoperation rates, with echocardiography for failure rate estimation.
- Propensity score analysis was used to control for confounding factors.
Main Results:
- Mitral valve plasty was associated with significantly lower total mortality (RR = 0.43, p = 0.002) compared to MVR, even after adjusting for 3-vessel disease.
- MPL showed a lower reoperation rate in patients without atrial fibrillation (AF), but similar rates in those with AF.
- Long-term failure rates for MPL were found to be low.
Conclusions:
- Mitral valve plasty demonstrates superior survival and reduced reoperation rates compared to mitral valve replacement for mitral valve disease.
- Clinical management should focus on controlling risk factors for atrial fibrillation to improve MPL outcomes.
- Further validation through randomized clinical trials is recommended to confirm these findings.
More Related Videos
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis II: Clinical features and Diagnostic Tests